HUE041356T2 - Hydroxyalkyl starch for the treatment of cancers by reduction of tumor growth rates - Google Patents

Hydroxyalkyl starch for the treatment of cancers by reduction of tumor growth rates

Info

Publication number
HUE041356T2
HUE041356T2 HUE13701646A HUE13701646A HUE041356T2 HU E041356 T2 HUE041356 T2 HU E041356T2 HU E13701646 A HUE13701646 A HU E13701646A HU E13701646 A HUE13701646 A HU E13701646A HU E041356 T2 HUE041356 T2 HU E041356T2
Authority
HU
Hungary
Prior art keywords
cancers
reduction
treatment
tumor growth
growth rates
Prior art date
Application number
HUE13701646A
Other languages
Hungarian (hu)
Inventor
Martin Westphal
Silke Baasner
Original Assignee
Fresenius Kabi Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Deutschland Gmbh filed Critical Fresenius Kabi Deutschland Gmbh
Publication of HUE041356T2 publication Critical patent/HUE041356T2/en

Links

HUE13701646A 2012-01-30 2013-01-30 Hydroxyalkyl starch for the treatment of cancers by reduction of tumor growth rates HUE041356T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261592017P 2012-01-30 2012-01-30
EP12153068 2012-01-30

Publications (1)

Publication Number Publication Date
HUE041356T2 true HUE041356T2 (en) 2019-05-28

Family

ID=65474822

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE13714546A HUE040080T2 (en) 2012-01-30 2013-01-30 Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates
HUE13701646A HUE041356T2 (en) 2012-01-30 2013-01-30 Hydroxyalkyl starch for the treatment of cancers by reduction of tumor growth rates

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HUE13714546A HUE040080T2 (en) 2012-01-30 2013-01-30 Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates

Country Status (4)

Country Link
CY (2) CY1121443T1 (en)
HR (1) HRP20181814T1 (en)
HU (2) HUE040080T2 (en)
PT (2) PT2809329T (en)

Also Published As

Publication number Publication date
CY1121443T1 (en) 2020-05-29
HUE040080T2 (en) 2019-02-28
PT2809327T (en) 2018-11-16
CY1121445T1 (en) 2020-05-29
HRP20181814T1 (en) 2019-03-22
PT2809329T (en) 2018-11-16

Similar Documents

Publication Publication Date Title
IL258612B (en) Anti-angiogenesis therapy for the treatment of ovarian cancer
HK1254859A1 (en) Methods for the treatment of breast cancer
IL237558A0 (en) Methods for the treatment of locally advanced breast cancer
IL238942B (en) Pyrimidine-2,4-diamine derivatives for treatment of cancer
HK1206338A1 (en) Pyrimidine compounds for the treatment of cancer
EP2925752A4 (en) Pyrimidine compounds for the treatment of cancer
HK1202122A1 (en) Combination therapy for the treatment of ovarian cancer
HK1185874A1 (en) Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer 4--n--
HRP20181754T1 (en) Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates
HK1204605A1 (en) Functionalized thieno-indole derivatives for the treatment of cancer
HK1223832A1 (en) Kinase inhibitors for the treatment of cancer
PL2855475T3 (en) Alpha-carbolines for the treatment of cancer
HRP20181814T1 (en) Hydroxyalkyl starch for the treatment of cancers by reduction of tumor growth rates
HK1202118A1 (en) Piperazinyl derivatives for the treatment of cancer
ZA201307677B (en) Anti-angiogenesis therapy for the treatment of ovarian cancer
HK1200094A1 (en) Use of immunomodulators for the treatment of cancer
PT2925744T (en) Pyrimidine-2,4-diamine derivatives for treatment of cancer